STUB1 and hyperlipidemia: Surprisingly, CHIP (2% or 6% in diet, m/m) did not provide a significant effect on hyperlipidemia (Figures 4A–D) and body weight gain (Figure 4E), but the high-dose CHIP significantly enhanced the hepatic enzyme activity levels of GPx, GST and TrxR (Figures 4H–J).